Partner Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Partner Investment Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,735	Closed	-$630K	–	112
2015 Q2	$630K	Buy	12,735 +5,579	+78%	+$334K	0.89%	46
2015 Q1	$560K	Buy	7,156 +4	+0.1%	+$248	0.84%	48
2014 Q4	$433K	Sell	7,152 -3,530	-33%	-$177K	0.18%	66
2014 Q3	$455K	Sell	10,682 -6,570	-38%	-$353K	0.17%	45
2014 Q2	$1.07M	Sell	17,252 -13,236	-43%	-$770K	0.21%	45
2014 Q1	$1.98M	Buy	30,488 +6,466	+27%	+$437K	0.37%	43
2013 Q4	$1.35M	Buy	24,022 +6,163	+35%	+$346K	0.31%	38
2013 Q3	$1.09M	Sell	17,859 -1,014	-5%	-$68.7K	0.29%	42
2013 Q2	$1.1M	Buy	+18,873	New	+$1.16M	0.25%	45

Other funds holding OREX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Partner Investment Management's OREX Position: Q3 2015 in Review

Partner Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2015, closing a stake of 12,735 shares — an estimated $630K sold.

Partner Investment Management first reported a position in OREX in Q2 2013 and held it in 9 quarters. The position peaked at $1.98M in Q1 2014. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

Partner Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Partner Investment Management sold 12,735 Orexigen Therapeutics, Inc. shares in Q3 2015, an estimated $630K.
Partner Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 9 quarters.
Partner Investment Management's Orexigen Therapeutics, Inc. position peaked at $1.98M in Q1 2014.
132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on Partner Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.